FDA Grants Cytori 510(k) Clearance for Puregraft(R) 850
Cytori (NASDAQ: CYTX) has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the Puregraft®…
Cytori (NASDAQ: CYTX) has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the Puregraft®…
Cytori Therapeutics (Nasdaq:CYTX) reports second quarter and first half 2010 financial results. Further details, includi…
Cytori announces the product launch of PureGraft 250, a revolutionary fat grafting technology that standardizes the graf…
Cytori Therapeutics (NASDAQ:CYTX) is reporting its financial results for the year ended December 31, 2009. More informat…
The FDA has granted Cytori Therapeutics (NASDAQ: CYTX) 510(k) marketing clearance for its PureGraft(TM) System. Cytori w…